List of Tables:

TABLE 1 GLOBAL CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION)
TABLE 2 GLOBAL CYSTIC FIBROSIS MEDICATION MARKET, BY REGION, 2013-2027 ($MILLION)
TABLE 3 GLOBAL CYSTIC FIBROSIS DEVICES MARKET, BY REGION, 2013-2027 ($MILLION)
TABLE 4 GLOBAL CYSTIC FIBROSIS OTHER TREATMENTS MARKET, BY REGION, 2013-2027 ($MILLION)
TABLE 5 GLOBAL CYSTIC FIBROSIS MARKET, BY REGION, 2013-2022 ($MILLION)
TABLE 6 North America CYSTIC FIBROSIS MARKET, BY COUNTRY, 2013-2022 ($MILLION)
TABLE 7 North America CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION)
TABLE 8 U.S. CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION)
TABLE 9 Canada CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION)
TABLE 10 EUROPE CYSTIC FIBROSIS MARKET, BY COUNTRY, 2013-2022 ($MILLION)
TABLE 11 EUROPE CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION)
TABLE 12 Germany CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION)
TABLE 13 France CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION)
TABLE 14 UK CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION)
TABLE 15 Italy CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION)
TABLE 16 SPAIN CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION)
TABLE 17 REST OF WESTERN EUROPE CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION)
TABLE 18 EASTERN EUROPE CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION)
TABLE 19 ASIA-PACIFIC CYSTIC FIBROSIS MARKET, BY COUNTRY, 2013-2022 ($MILLION)
TABLE 20 ASIA-PACIFIC CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION)
TABLE 21 AUSTRALIA CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION)
TABLE 22 JAPAN CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION)
TABLE 23 China CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION)
TABLE 24 India CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION)
TABLE 25 REPUBLIC OF KOREA CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION)
TABLE 26 REST OF ASIA-PACIFIC CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION)
TABLE 27 MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET, BY REGION, 2013-2022 ($MILLION)
TABLE 28 MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION)
TABLE 29 MIDDLE EAST CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION)
TABLE 30 AFRICA CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION)
TABLE 31 CHIESI FARMACEUTICI S.P.A.: KEY DEVELOPMENTS
TABLE 32 VERTEX PHARMACEUTICALS INCORPORATED: KEY DEVELOPMENTS

LIST OF FIGURE

List of Figures:

FIGURE 1 RESEARCH PROCESS OF MRFR
FIGURE 2 PORTER'S 5 FORCES ANALYSIS OF GLOBAL CYSTIC FIBROSIS MARKET
FIGURE 3 GLOBAL CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2015 & 2022 ($MILLION)
FIGURE 4 GLOBAL CYSTIC FIBROSIS MARKET, BY REGION, 2015 (%)
FIGURE 5 North America CYSTIC FIBROSIS MARKET, BY COUNTRY, 2015 (%)
FIGURE 6 North America CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2015 & 2022 ($MILLION)
FIGURE 7 EUROPE CYSTIC FIBROSIS MARKET, BY COUNTRY, 2015 (%)
FIGURE 8 EUROPE CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2015 & 2022 ($MILLION)
FIGURE 9 ASIA-PACIFIC CYSTIC FIBROSIS MARKET, BY COUNTRY, 2015 (%)
FIGURE 10 ASIA-PACIFIC CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2015 % 2022 ($MILLION)
FIGURE 11 MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET, BY REGION, 2015 (%)
FIGURE 12 MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2015 & 2022 ($MILLION)
FIGURE 13 CYSTIC FINROSIS MARKET SHARE, 2016 (%)
FIGURE 14 ABBVIE: RECENT FINANCIAL
FIGURE 15 ABBVIE: BUSINESS REVENUE, 2015 (%)
FIGURE 16 ABBVIE: GEOGRAPHIC REVENUE, 2015 (%)
FIGURE 17 ALLERGAN: RECENT FINANCIAL
FIGURE 18 ALLERGAN: BUSINESS REVENUE, 2015 (%)
FIGURE 19 ALLERGAN: GEOGRAPHIC REVENUE, 2015 (%)
FIGURE 20 CHIESI FARMACEUTICI S.P.A.: RECENT FINANCIALS
FIGURE 21 F. HOFFMANN-LA ROCHE AG.: RECENT FINANCIALS
FIGURE 22 F. HOFFMANN-LA ROCHE AG.: BUSINESS REVENUE
FIGURE 23 GILEAD SCIENCES: RECENT FINANCIAL
FIGURE 24 NOVARTIS AG: RECENT FINANCIALS
FIGURE 25 NOVARTIS AG: BUSINESS REVENUE, 2015 (%)
FIGURE 26 NOVARTIS AG: GEOGRAPHIC REVENUE, 2015 (%)
FIGURE 27 PHARMAXIS LTD: RECENT FINANCIALS
FIGURE 28 PTC THERAPEUTICS: RECENT FINANCIALS
FIGURE 29 PTC THERAPEUTICS: GEOGRAPHICAL REVENUE (%)
FIGURE 30 PTC THERAPEUTICS: R&D EXPENSES, 2015 (%)
FIGURE 31 VERTEX PHARMACEUTICALS INCORPORATED: RECENT FINANCIALS
FIGURE 32 VERTEX PHARMACEUTICALS INCORPORATED: BUSINESS REVENUE
FIGURE 33 VERTEX PHARMACEUTICALS INCORPORATED: GEOGRAPHICAL REVENUE